Head-to-head · WeighScore
Livea vs TrueMe
The verdict
Livea takes it — 69.7/100 to 67.4/100.
Livea grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Livea is a physician-supervised medical weight loss clinic founded in 2011 with 8 clinics in MN and WI, plus telehealth in MN, WI, Iowa, and Florida.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Livea | TrueMe |
|---|---|---|
| WeighScore | 69.7/100 | 67.4/100 |
| Grade | C | C |
| Scorecard rank | #123 | #171 |
| Semaglutide | $99/mo (plus a separate fee, compounded) | $159/mo (compounded) |
| Tirzepatide | $199/mo (compounded) | $189/mo (compounded) |
| Coverage | 4 states | 6 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #123 · C
Strengths
- LegitScript certified; physician-owned Livea Medical PLLC; Medical Director Dr. Paul Olson, internal medicine/nephrology, 40 years experience
- Compounded sema from $99/mo and tirz from $199/mo — significantly cheaper than brand Ozempic/Wegovy ($1,000+/mo self-pay)
- Comprehensive program: InBody scans, registered dietitian nutrition counseling, health coaching, and regular provider check-ins included
- 15+ years established (founded 2011); 50,000+ clients served; voted Minnesota's Best Weight Loss Program 5 consecutive years
- Medications shipped to door; same-day consultations; in-person or telehealth; typically HSA/FSA eligible
Where it loses points
- Telehealth limited to 4 states only (MN, WI, IA, FL) — unavailable to most of the US; primarily a regional clinic network
- Pricing ambiguous: $69/mo program fee plus separate medication cost ($99/mo sema) may bring GLP-1 total to ~$168/mo
- Compounded tirzepatide availability uncertain — FDA announced shortage end in 2026; access subject to eligibility
- Labs (bloodwork) not explicitly included in any published program tier; confirmed at consultation only
- Strong MN/WI clinic focus; telehealth reach into IA and FL is newer and less established than core markets
Graded #171 · C
Strengths
- One price covers consultation, medication, shipping, supplies and provider support, and the site states there are no separate membership fees
- Same price at every dose, so the cost does not climb as a provider titrates the dose upward
- Full pricing is published up front — no intake form is required before you can see what you will pay
- Carries a genuine LegitScript-issued seal (ID 50205625) that resolves on LegitScript's own asset host
- Names its telehealth platform (Telegra) and physician network (Strive), and the returns address names CarePoint Infusion Pharmacy in Stafford, Texas
Where it loses points
- Serves only six states (AZ, CO, MO, PA, TX, WI), far narrower coverage than most national GLP-1 telehealth
- Prices marketed per month are charged every 4 weeks at checkout — 13 charges a year, not 12
- You pay before completing the medical intake, and approval is not guaranteed at the moment you are charged
- The 3-month rates ($119 and $139/mo) are a single upfront charge of $357 or $417, not a lower monthly plan
- A Featured In strip shows CNN, Fox News, Forbes, New York Times and NPR logos with no linked coverage
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.